Search
Inozyme Pharma Inc
INZYAdd to Watchlist
4.000USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
257.88MMarket Cap
LossP/E TTM
Inozyme Pharma Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-1.62
-18.31%
Analyst Rating
HOLD
2025-07-02
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Inozyme Pharma Inc?
According to Inozyme Pharma Inc's FY2024 earnings report, its current assets were 120.68M, with a year-on-year change of -38.51.
What are the total assets of Inozyme Pharma Inc?
According to Inozyme Pharma Inc's FY2024 earnings report, its total assets of Inozyme Pharma Inc were 123.18M, with a year-on-year change of -38.67.
What are the total liabilities of Inozyme Pharma Inc?
According to Inozyme Pharma Inc's FY2024 earnings report, its total liabilities of Inozyme Pharma Inc were 65.36M, with a year-on-year change of 8.26.
What is the total equity of Inozyme Pharma Inc?
According to Inozyme Pharma Inc's FY2024 earnings report, its total equity of Inozyme Pharma Inc was 57.83M, with a year-on-year change of -58.84.
What is the net investment of Inozyme Pharma Inc?
According to Inozyme Pharma Inc's FY2024 earnings report, its net investment of Inozyme Pharma Inc was 67.00M, with a year-on-year change of 224.89.
What is the net financing of Inozyme Pharma Inc?
According to Inozyme Pharma Inc's FY2024 earnings report, its net financing of Inozyme Pharma Inc was 11.40M, with a year-on-year change of -90.95.
What is the Earnings Per Share (EPS) of Inozyme Pharma Inc?
According to Inozyme Pharma Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -1.62, with a year-on-year change of -18.31.
What is the debt-to-asset ratio of Inozyme Pharma Inc?
According to Inozyme Pharma Inc's FY2024 earnings report, its debt-to-asset ratio was 37.31, with a year-on-year change of 67.39.
What is the Return on Equity (ROE) of Inozyme Pharma Inc?
According to Inozyme Pharma Inc's FY2024 earnings report, its Return on Equity (ROE) was -102.90, with a year-on-year change of -87.14.
What is the Return on Assets (ROA) of Inozyme Pharma Inc?
According to Inozyme Pharma Inc's FY2024 earnings report, its Return on Assets (ROA) was -62.97, with a year-on-year change of -50.44.
What is the operating profit of Inozyme Pharma Inc?
According to Inozyme Pharma Inc's FY2024 earnings report, its operating profit was -104.03M, with a year-on-year change of -37.52.